Budesonide Administration Frequency
Budesonide (Budecort) is typically administered twice daily (bd) for most formulations and indications. 1
Administration Guidelines by Formulation
Inhaled Budesonide for Asthma
- Dry Powder Inhaler (DPI): Administered twice daily for most patients 1
- Nebulized suspension:
Budesonide for Eosinophilic Esophagitis
- Adults: Orodispersible budesonide tablets at 0.5-1.0 mg twice daily for maintenance therapy 1, 2
- Children: Oral viscous budesonide (OVB) at 1 mg/day if <150 cm or 2 mg/day if >150 cm, either as a single dose or divided into two doses per day 1, 2
Dosing Considerations
Asthma Management
- Budesonide dosing depends on asthma severity, age, and formulation:
Gastrointestinal Conditions
- Microscopic Colitis: Budesonide 9 mg daily is recommended as first-line therapy, which can be administered once daily 1
- Eosinophilic Esophagitis: Twice daily administration is standard for maintenance therapy 1
Clinical Efficacy and Pharmacokinetics
- The efficacy of twice-daily administration has been well-established in multiple clinical trials 4
- A study comparing four-times-a-day versus twice-daily dosing found that twice-daily dosing was effective for most patients requiring ≤1200 mcg daily 5
- Once-daily administration may be effective for maintenance therapy in mild asthma but twice-daily dosing is generally preferred for moderate to severe asthma 3, 6
Important Administration Considerations
- Proper administration technique is crucial for efficacy
- For inhaled formulations, use of a spacer or valved holding chamber with non-breath-actuated MDIs is recommended 1
- Mouthwashing and spitting after inhalation decreases local side effects such as oral thrush 1
- For nebulized budesonide, use only jet nebulizers as ultrasonic nebulizers are ineffective for suspensions 1
Potential Adverse Effects
- Common side effects include cough, dysphonia, and oral thrush (candidiasis) 1
- At high doses, systemic effects may occur, though studies are not conclusive 1
- In children, low-to-medium doses may cause transient suppression of growth velocity 1
Pitfalls to Avoid
- Budesonide preparations are not interchangeable on a mcg or per-puff basis 1, 2
- Potent inhibitors of CYP 3A4 (e.g., ritonavir, ketoconazole) can increase systemic concentrations of budesonide 1
- Dose should be carefully titrated to the minimum effective dose once asthma control is achieved 1
While some formulations of budesonide may be administered once daily for certain conditions, the standard administration frequency for Budecort is twice daily (bd) for most indications.